Zoonotic Characteristics of Monkeypox: Living Evidence Profile
With this living evidence profile, we aim to evaluate accumulating evidence related to the animal and zoonotic characteristics of the monkeypox virus, understand their relevance to the Canadian context and identify important gaps in evidence.
The Hunan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic
A recent study addressing the origins of the COVID-19 pandemic has been published in the journal Science by a team of 18 scientists led by Michael Worobey and including CoVaRR-Net Pillar 2 lead Angela Rasmussen, virologist at the University of Saskatchewan’s Vaccine and Infectious Disease Organization, and an adjunct professor of biochemistry, microbiology, and immunology at the University of Saskatchewan.
Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases
Immune mediated inflammatory diseases (IMID), such as arthritis, inflammatory bowel diseases and severe inflammatory skin diseases such as psoriasis and hidradenitis suppurativa are often treated with systemic medication or biologics that can reduce inflammation.
COVID-19 Vaccination and Public Health Countermeasures on Variants of Concern in Canada: Evidence From a Spatial Hierarchical Cluster Analysis
With variants of concern (VOCs) continuing to emerge and pose health challenges in Canada, scientists, including Dr. Nazeem Muhajarine from the University of Saskatchewan and CoVaRR-Net Pillar 8 Public Health, Health Systems and Social Policy Impacts Co-Lead, are strategizing on how to control their effects on the Canadian population.
COVID-19 Vaccination Rollout: Nova Scotia
Nova Scotia’s strategy was to immunize 75% of its population by the end of September 2021. The province adopted a highly centralized vaccination campaign starting with its leadership structure.
COVID-19 Vaccination Rollout: British Columbia
British Columbia’s goal was to vaccinate all eligible residents by September 2021. Its vaccination campaign leadership was highly centralized, but also characterized by high levels of coordination between key stakeholders and health organizations.
Promising new molecule discovered in Canada shown to block SARS-CoV-2 could be developed as a nasal spray drug for COVID-19
Scientists, including some here in Canada, are contributing to the development of nasal-spray medications that would protect against numerous COVID-19 variants.
The Creation of a Centralized Database for Wastewater and Environmental Surveillance
The Public Health and Environmental Surveillance Database (PHESD, pronounced “phased”) is a data repository used to store Canadian and international wastewater and other environmental surveillance data.
Developing a Model to Record Wastewater and Environmental Surveillance Data
CoVaRR-Net researchers have been helping to build the Public Health and Environmental Surveillance Open Data Model (PHES-ODM).